Resultados de la búsqueda 81-90 of 715 for Golgi
Bile acid malabsorption (BAM)) occurs in about 1 in 3 patients with IBS-D and up to 50 percent of those with functional diarrhea, yet it remains underdiagnosed.
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...
Diffuse: The cancer cells have spread beyond the tumor and into healthy brain tissue. Midline: The tumor is found in the middle section of the central nervous ...
The purpose of this study is to evaluate invasive disease-free survival (iDFS) of multi-epitope HER2 vaccine vs. placebo in combination with ado-trastuzumab ...
The purpose of this study is to evaluate how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic Wilms ...
Md Shahrier Amin, M.B.B.S., Ph.D. Jacksonville, FL. Marie-Christine Aubry, M.D.. Rochester, MN.
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
Rochester, Minn. The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with ...
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
Surgeons have been slow to adopt laparoscopic pancreaticoduodenectomy (PD). · Research · A majority of patients with fecal incontinence experience at least a 50 ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?